BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31680412)

  • 1. Medically actionable comorbidities in adults with Costello syndrome.
    Shikany AR; Baker L; Stabley DL; Robbins K; Doyle D; Gripp KW; Weaver KN
    Am J Med Genet A; 2020 Jan; 182(1):130-136. PubMed ID: 31680412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic spectrum of Costello syndrome individuals harboring the rare HRAS mutation p.Gly13Asp.
    Bertola D; Buscarilli M; Stabley DL; Baker L; Doyle D; Bartholomew DW; Sol-Church K; Gripp KW
    Am J Med Genet A; 2017 May; 173(5):1309-1318. PubMed ID: 28371260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in Cancer.
    Hartung AM; Swensen J; Uriz IE; Lapin M; Kristjansdottir K; Petersen US; Bang JM; Guerra B; Andersen HS; Dobrowolski SF; Carey JC; Yu P; Vaughn C; Calhoun A; Larsen MR; Dyrskjøt L; Stevenson DA; Andresen BS
    PLoS Genet; 2016 May; 12(5):e1006039. PubMed ID: 27195699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory system involvement in Costello syndrome.
    Gomez-Ospina N; Kuo C; Ananth AL; Myers A; Brennan ML; Stevenson DA; Bernstein JA; Hudgins L
    Am J Med Genet A; 2016 Jul; 170(7):1849-57. PubMed ID: 27102959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An attenuated phenotype of Costello syndrome in three unrelated individuals with a HRAS c.179G>A (p.Gly60Asp) mutation correlates with uncommon functional consequences.
    Gripp KW; Sol-Church K; Smpokou P; Graham GE; Stevenson DA; Hanson H; Viskochil DH; Baker LC; Russo B; Gardner N; Stabley DL; Kolbe V; Rosenberger G
    Am J Med Genet A; 2015 Sep; 167A(9):2085-97. PubMed ID: 25914166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HRAS mutants identified in Costello syndrome patients can induce cellular senescence: possible implications for the pathogenesis of Costello syndrome.
    Niihori T; Aoki Y; Okamoto N; Kurosawa K; Ohashi H; Mizuno S; Kawame H; Inazawa J; Ohura T; Arai H; Nabatame S; Kikuchi K; Kuroki Y; Miura M; Tanaka T; Ohtake A; Omori I; Ihara K; Mabe H; Watanabe K; Niijima S; Okano E; Numabe H; Matsubara Y
    J Hum Genet; 2011 Oct; 56(10):707-15. PubMed ID: 21850009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal costello syndrome with neuromuscular spindles excess and p.Gly12Val HRAS mutation.
    Quélin C; Loget P; Rozel C; D'Hervé D; Fradin M; Demurger F; Odent S; Pasquier L; Cavé H; Marcorelles P
    Eur J Med Genet; 2017 Jul; 60(7):395-398. PubMed ID: 28455154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paternal uniparental disomy 11p15.5 in the pancreatic nodule of an infant with Costello syndrome: Shared mechanism for hyperinsulinemic hypoglycemia in neonates with Costello and Beckwith-Wiedemann syndrome and somatic loss of heterozygosity in Costello syndrome driving clonal expansion.
    Gripp KW; Robbins KM; Sheffield BS; Lee AF; Patel MS; Yip S; Doyle D; Stabley D; Sol-Church K
    Am J Med Genet A; 2016 Mar; 170(3):559-64. PubMed ID: 26572961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome: a Ras/MAPK pathway syndrome.
    Lin AE; Alexander ME; Colan SD; Kerr B; Rauen KA; Noonan J; Baffa J; Hopkins E; Sol-Church K; Limongelli G; Digilio MC; Marino B; Innes AM; Aoki Y; Silberbach M; Delrue MA; White SM; Hamilton RM; O'Connor W; Grossfeld PD; Smoot LB; Padera RF; Gripp KW
    Am J Med Genet A; 2011 Mar; 155A(3):486-507. PubMed ID: 21344638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic profiling of Costello syndrome: Insights from a single-center cohort.
    Leoni C; Massese M; Gervasoni J; Primiano A; Giorgio V; Onesimo R; Kuczynska E; Rigante D; Persichilli S; Carpentieri G; Flex E; Pastorino R; Tartaglia M; Zampino G
    Eur J Med Genet; 2022 Mar; 65(3):104439. PubMed ID: 35101635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costello syndrome with special cutaneous manifestations and HRAS G12D mutation: A case report and literature review.
    Qian W; Zhang M; Huang H; Chen Y; Park G; Zeng N; Li Y; Lu Q; Luo D
    Mol Genet Genomic Med; 2021 Jun; 9(6):e1690. PubMed ID: 33932139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excess of neuromuscular spindles in a fetus with Costello syndrome: a clinicopathological report.
    Sinico M; Bassez G; Touboul C; Cavé H; Vergnaud A; Zirah C; Fleury-Feith J; Gettler S; Vojtek AM; Chevalier N; Amram D; Alsamad IA; Haddad B; Encha-Razavi F
    Pediatr Dev Pathol; 2011; 14(3):218-23. PubMed ID: 20658932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal dystrophy in two boys with Costello syndrome due to the HRAS p.Gly13Cys mutation.
    Pierpont ME; Richards M; Engel WK; Mendelsohn NJ; Summers CG
    Am J Med Genet A; 2017 May; 173(5):1342-1347. PubMed ID: 28337834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatological phenotype in Costello syndrome: consequences of Ras dysregulation in development.
    Siegel DH; Mann JA; Krol AL; Rauen KA
    Br J Dermatol; 2012 Mar; 166(3):601-7. PubMed ID: 22098123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duplication of Glu37 in the switch I region of HRAS impairs effector/GAP binding and underlies Costello syndrome by promoting enhanced growth factor-dependent MAPK and AKT activation.
    Gremer L; De Luca A; Merbitz-Zahradnik T; Dallapiccola B; Morlot S; Tartaglia M; Kutsche K; Ahmadian MR; Rosenberger G
    Hum Mol Genet; 2010 Mar; 19(5):790-802. PubMed ID: 19995790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel patient with an attenuated Costello syndrome phenotype due to an HRAS mutation affecting codon 146-Literature review and update.
    Chiu AT; Leung GK; Chu YW; Gripp KW; Chung BH
    Am J Med Genet A; 2017 Apr; 173(4):1109-1114. PubMed ID: 28328122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costello syndrome: Clinical phenotype, genotype, and management guidelines.
    Gripp KW; Morse LA; Axelrad M; Chatfield KC; Chidekel A; Dobyns W; Doyle D; Kerr B; Lin AE; Schwartz DD; Sibbles BJ; Siegel D; Shankar SP; Stevenson DA; Thacker MM; Weaver KN; White SM; Rauen KA
    Am J Med Genet A; 2019 Sep; 179(9):1725-1744. PubMed ID: 31222966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic analysis of individuals with Costello syndrome due to HRAS p.G13C.
    Gripp KW; Hopkins E; Sol-Church K; Stabley DL; Axelrad ME; Doyle D; Dobyns WB; Hudson C; Johnson J; Tenconi R; Graham GE; Sousa AB; Heller R; Piccione M; Corsello G; Herman GE; Tartaglia M; Lin AE
    Am J Med Genet A; 2011 Apr; 155A(4):706-16. PubMed ID: 21438134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of a duplication (p.E63_D69dup) in the switch II region of HRAS: new aspects of the molecular pathogenesis underlying Costello syndrome.
    Lorenz S; Lissewski C; Simsek-Kiper PO; Alanay Y; Boduroglu K; Zenker M; Rosenberger G
    Hum Mol Genet; 2013 Apr; 22(8):1643-53. PubMed ID: 23335589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing genotype-phenotype correlation in Costello syndrome using a severity score.
    McCormick EM; Hopkins E; Conway L; Catalano S; Hossain J; Sol-Church K; Stabley DL; Gripp KW
    Genet Med; 2013 Jul; 15(7):554-7. PubMed ID: 23429430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.